Navigation Links
Angiotech and Symphony Medical Announce Licensing Agreement
Date:1/17/2008

lation device. The concept is protected by a number of patents which are currently pending.

"We are excited about the opportunity to work with Angiotech's biomaterial to address a large unmet clinical need in POAF. According to numerous clinical studies, on average, 40 percent of patients who undergo CABG and coronary valve surgeries develop atrial fibrillation. Based on the success of our preclinical animal model, we have already received EU and Institutional Review Board approval for our 60 patient multi-center 'randomized safety study' in Germany and expect to begin enrolling patients in the first quarter of 2008," said Raymond W. Cohen, CEO of Symphony.

Under the terms of the agreement, Angiotech has been granted an equity position in Symphony Medical in exchange for the exclusive license of Angiotech's technology in the field of POAF. In addition, Angiotech will receive a royalty on end-user product sales should the product receive regulatory approval and is commercialized.

About Post-Operative Atrial Fibrillation (AF)(1)

Atrial fibrillation is a common arrhythmia following open heart surgery that is associated with increased morbidity and mortality. Patients who develop postoperative atrial fibrillation are more likely to have other postoperative complications such as peri-operative MI, CHF and respiratory failure(2). Postoperative atrial fibrillation is associated with longer ICU and hospital stays and consequently, the economic cost can be considerable(3).

About Angiotech

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,600 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit http://www.ang
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
2. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
3. Angiotech to participate in RBC 2007 Healthcare Conference
4. Angiotech to participate in Bank of America 2007 Credit Conference
5. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
8. Angiotech to participate in UBS Global Life Sciences Conference
9. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
10. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... NeoStem, Inc.,(NYSE Alt...se collection,processing and long-term storage o... announced that it has reached a major milestone i...he first ever collection center for collection of,... medical need in New York,City and has chosen Bru...
(Date:12/4/2008)..., Dec. 4 MedImmune today announced...n patients with chronic asthma to,determine the s...onal antibody,(MAb) that targets the interleukin-... inhibiting the IL-5R pathway may lead to a target...pporting continued study of this antibody. , ...
(Date:12/4/2008)...4 Azur Pharma Limited ("Azur") tod...e agreement with BioSante,Pharmaceuticals, Inc ("... to,Elestrin(TM). Elestrin is a fast drying gel f...e treatment of moderate to severe vasomotor sympto...ed by the U.S. Food and Drug,Administration ("FDA...
(Date:12/4/2008)...roduces New Trade Name Onrigin(TM) for Laromustine...irstCall/ -- VION PHARMACEUTICALS, INC. (OTC Bull...s related to events in connection with the 50th Am... Moscone Center in San Francisco from December 6-9..., , The Company announced that it would pre...
Breaking Biology Technology:NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 4MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 2MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 3Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4
...eus assays • toxicology • image analysis...ucleus induction is a key characteristic of genoto...n resulting from DNA strand breakage (clastogens) ...ens) is an important component of toxicology scree...ronucleus assays is time consuming and subject to ...
...1 , Rao S. Takkellapati 1 , Kate Lavrenov 1 , Scot... GE Healthcare, Piscataway, NJ, USA , , ...f Cambridge, Cambridge, UK , , ,...most commonly used methods for amplification of ge...diated PCR is one of several current strategies be...
...er • apoptosis • multiplexing &bull... represents a gene-directed, morphologically and b...h. Inappropriate control of apoptosis is associate... AIDS, neurodegenerative diseases, and ischaemic s...is is extremely important when considering the eff...
...l vector • viral transduction • EGFP &bu... , There is a requirement in the drug disc...arising from primary screens and to validate those... also a need in early-stage drug discovery to iden... of, a plethora of molecular targets involved in s...
Other Biology Technology:Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 2Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 3Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 4Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 5GenomiPhi: protocol for BAC amplification and fabrication of slides for array CGH 2GenomiPhi: protocol for BAC amplification and fabrication of slides for array CGH 3GenomiPhi: protocol for BAC amplification and fabrication of slides for array CGH 4The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 2The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 3The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 4The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 5The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 6The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 7Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 2Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 3Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 4Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 5Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 6Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 7Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 8Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 9Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 10
(Date:12/3/2008)...utive director of the International Energy Agency,... 9 at Rice University,s Baker Institute for Public... Is the world facing a supply crunch because of ge...Kyoto policy framework might stabilize greenhouse ... might such a policy framework have on future ener...
(Date:12/3/2008)...2008. The first 5-year forest inventory report for...e to the public: Oregon,s Forest Resources, 2001-2...t. , Here are some key findings from the report:...s; about half of Oregon,s total land area of 61 mi...other uses particularly near urban areas. The rate...
(Date:12/3/2008)...sity study suggests that evolution can behave as d... on an energy-efficient style of four-footed runni...eem to have evolved a profoundly inefficient gait,...w motion. , "It is usually assumed that efficien...itt, a Duke associate professor of evolutionary an...
(Date:12/3/2008)...ldren failing to take their medication for a range... part of a new university research project. , Th...he University of Nottingham and The University of ...hildren with asthma, diabetes, congenital heart di...t prevent them from taking medicines prescribed fo...
Breaking Biology News(10 mins):'World Energy Outlook' to be presented at Rice University Dec. 9 2Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Dogs chase efficiently, but cats skulk counterintuitively 2A spoonful of sugar? 2A spoonful of sugar? 3CVS Caremark Launches the 2008 Season of the CVS Caremark All Kids Can 28TM 29 Baseball Camps at Fenway Park 21598 1CVS Caremark Launches the 2008 Season of the CVS Caremark All Kids Can 28TM 29 Baseball Camps at Fenway Park 21598 2Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX 4 in Allergic Rhinitis 2395 1Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX 4 in Allergic Rhinitis 2395 2European businesses not properly advised on how to prepare for flu pandemic 21593 1European businesses not properly advised on how to prepare for flu pandemic 21593 2Disturbed rest activity linked to mortality in older men 21589 1Disturbed rest activity linked to mortality in older men 21589 2
...he fruitfly genome, Johns Hopkins scientists have ...ll migration and simultaneously captured a global ...the move. , The study, to be published April 3 in...nding cell migration and perhaps controlling cance...iginal tumor, which are what eventually kills most...
...ly and Virginia Tech in the United States have det...ible for the production xanthurenic acid (XA) in A... XA plays a key role in the sexual reproduction of.... gambiae mosquitoes. Interfering with the formati...gs and insecticides to block malaria transmission....
...w that regular use of popular prescription pain re... to 71 percent and may offer similar benefit in th... , The study findings were released today at the a...er Research in Washington, D.C. , "We believe th... inhibitors have significant chemopreventive effec...
...r ants it,s a way of life! Scientists at the Unive... to learn how to visually judge the height of hori...l under it without slowing down. Tobias Seidl will... Annual Meeting for the Society for Experimental B...ly scurry around at high speeds whilst foraging to...
Other Biology News:Researchers identify genes in fruitflies that may shed light on human cancer spread 2Oxidation defense in mosquitoes benefits malaria parasite 2COX-2 inhibitors significantly reduce risk of cancer 2
Hygromycin resistance gene (hph), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin.
...plate is designed to allow neomycin/kanamycin sele...T-PGK-gb2-neo-FRT template encodes the neomycin/ka...ic promoter (gb2) for expression of kanamycin resi...) for expression of neomycin resistance in mammali...
This depletion cocktail is tailored to highly enrich CD4+ T cells from suspensions of rat spleen cells. Cells are separated using the StemSep (or compatible 0.5 Tesla) immunomagnetic negative cell se
Application: A tracking dye for nucleic acid electrophoresis in agarose or polyacrylamide gels including DNA sequencing. Preparation Quantity Equivalency: A final concentration of 0.05% is recommende
Biology Products: